Guo Xianfeng, male deputy chief physician, was born in 1952 and graduated from Jilin medical college in 1975. He has worked in the Affiliated Hospital of Beijing First Medical University and the Provincial People's Hospital. He has been devoted to the research and treatment of hemangioma for more than 20 years. Using superconducting ablation technology, drugs are directly introduced into hemangioma under the guidance of ultrasound, and light waves are irradiated, so that hemangioma endothelial cells lose their activity and die gradually. He has high attainments in the treatment of hemangioma with radionuclide 90 strontium technology combined with superconducting interventional ablation technology and superconducting light wave minimally invasive interventional technology. After years of clinical research and practice, he has unique views on the treatment of strawberry hemangioma, capillary hemangioma, cavernous hemangioma, port wine nevus, mixed hemangioma, lymphangioma, tendinous hemangioma and other hemangioma in children. This therapy has the characteristics of no operation, no hospitalization, no pain and no scar after healing. He published a paper in a provincial medical journal. Its rigorous medical style and noble medical ethics are well received by patients and their families.